mecamylamine has been researched along with Anasarca in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandre, M | 1 |
| Uduman, AK | 1 |
| Minervini, S | 1 |
| Raoof, A | 1 |
| Shugrue, CA | 1 |
| Akinbiyi, EO | 1 |
| Patel, V | 1 |
| Shitia, M | 1 |
| Kolodecik, TR | 1 |
| Patton, R | 1 |
| Gorelick, FS | 1 |
| Thrower, EC | 1 |
1 other study available for mecamylamine and Anasarca
| Article | Year |
|---|---|
Tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone initiates and enhances pancreatitis responses.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Atropine; Carcinogens; Cells, Cultured; Ceruletide | 2012 |